ERα degrader 5

• UNSPSC Description:

  ERα degrader 5 (Compound 40) is a selective, orally bioavailable estrogen receptor (ER) degrader (SERD) with an EC50 of 1.1 nM against ERα. ERα degrader 5 shows antitumor effect in vivo[1].

• Target Antigen:

  Estrogen Receptor/ERR

• Type:

  Reference compound

• Related Pathways:

  Vitamin D Related/Nuclear Receptor

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/erα-degrader-5.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC(F)(C1=C(C2=C(C3=CC=C4NN=CC4=C3S2)OC5=CC=C(C=C5)OC6CN(C6)CCCF)C=CC(F)=C1)F

• Molecular Weight:

  555.59

• References & Citations:

  [1]Zhengyu Lu, et al. Discovery of Thieno[2,3-e]indazole Derivatives as Novel Oral Selective Estrogen Receptor Degraders with Highly Improved Antitumor Effect and Favorable Druggability. J Med Chem. 2022 Apr 14;65(7):5724-5750.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2941268-96-6